
ViiV Healthcare Highlights Five-Year U.S. Real-World Evidence Supporting Cabenuva’s Long-Term Effectiveness and Treatment Persistence
ViiV Healthcare Reports Five-Year Real-World Evidence Supporting Long-Term Cabenuva Effectiveness in HIV Treatment ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, has…














